⌕
Artivion · AORT · NYSE
Tenet 37 · Weak
Compare
$18.27−1.08%At closeTenet 37 · Weak
$18.27−0.20 (−1.08%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Artivion (AORT) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is AORT's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Defense WorldNov 11, 2026 · 03:54 ETEARNINGS EXPECTED BY FEB 17
Financial Contrast: Zimmer Biomet (NYSE:ZBH) and Artivion (NYSE:AORT)

Zimmer Biomet (NYSE: ZBH - Get Free Report) and Artivion (NYSE: AORT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their p…

AORT −1.1% todayRead at source ↗
● MarketBeatNov 6, 2026 · 19:15 ETEARNINGS EXPECTED BY FEB 17
Artivion Q3 Earnings Call Highlights

Artivion NYSE: AORT reported 9% constant-currency revenue growth in the third quarter of 2026, while adjusted earnings declined as the medical device maker invested in manufacturing and prepared for the U.S. launch of it…

AORT −1.1% todayRead at source ↗
● Seeking AlphaNov 5, 2026 · 20:44 ETEARNINGS EXPECTED BY FEB 17
Artivion, Inc. (AORT) Q3 2026 Earnings Call Transcript

Artivion, Inc. (AORT) Q3 2026 Earnings Call Transcript…

AORT −1.1% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 18:46 ETEARNINGS EXPECTED BY FEB 17
Artivion (AORT) Lags Q3 Earnings Estimates

Artivion (AORT) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.16 per share a year ago.…

AORT −1.1% todayRead at source ↗
● PRNewsWireNov 5, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 17
Artivion Reports Third Quarter 2026 Financial Results

Third Quarter & Recent Business Highlights: Achieved revenue of $123.8 million in the third quarter of 2026 versus $113.4 million in the third quarter of 2025, an increase of 9% on a GAAP basis and 9% on a non-GAAP const…

AORT −1.1% todayRead at source ↗
● PRNewsWireOct 28, 2026 · 16:10 ETCOMPANY'S OWN WORDS
Artivion to Participate in Upcoming Investor Conferences

ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.…

AORT −1.1% todayRead at source ↗
● PRNewsWireOct 22, 2026 · 16:10 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 17
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results

ATLANTA, Oct. 22, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2026 financial results will be released on …

AORT −1.1% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 17. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just AORT · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.